Home Current Issue Previous Issues For Authors Journal Info
Skip Navigation LinksHome > January 2009 - Volume 19 - Issue 1 > Medication Use by Athletes at the Athens 2004 Summer Olympic...
Clinical Journal of Sport Medicine:
January 2009 - Volume 19 - Issue 1 - pp 33-38
doi: 10.1097/JSM.0b013e31818f169e
Original Research

Medication Use by Athletes at the Athens 2004 Summer Olympic Games

Tsitsimpikou, Christina PhD; Tsiokanos, Athanasios PhD; Tsarouhas, Konstantinos MD; Schamasch, Patrick MD; Fitch, Kenneth D MD; Valasiadis, Dimitrios PT; Jamurtas, Athanasios PhD

Collapse Box

Abstract

Objective: To gather data and examine the use by elite Olympic athletes of food supplements and pharmaceutical preparations in total and per sport, country, and gender.

Design: Survey study.

Setting: Athens 2004 Olympic Games (OG).

Participants: Data from 2 sources were collected: athletes' declaration of medications/supplements intake recorded on the Doping Control Official Record during sample collection for doping control, and athletes' application forms for granting of a therapeutic use exemption (TUE) and through the abbreviated TUE process (aTUE).

Main Outcome Measures: Classification of declared food supplements according to the active ingredient and medications according to therapeutic actions and active compounds.

Results: 24.3% of the athletes tested for doping control declared no use of medications or food supplements. Food supplements (45.3%) continue to be popular, with vitamins (43.2%) and proteins/aminoacids (13.9%) in power sports being most widely used. Nonsteroidal antiinflammatory agents and analgesics were also commonly used by athletes (11.1% and 3.7%, respectively). The use of the hemoderivative actovegin and several nonprohibited anabolic preparations are discussed. The prevalence of medication use for asthma and the dangers of drug interactions are also presented.

Laboratory analysis data reveal that of the aTUEs received for inhaled glucocorticosteroids, only budesonide was detectable in significant percentage (10.0%). Only 6.5% of the 445 athletes approved to inhale β2-agonists led to an adverse analytical finding.

Conclusions: This review demonstrates that overuse of food supplements was slightly reduced compared to previous OGs and a more rational approach to the use of medication is being adopted.

© 2009 Lippincott Williams & Wilkins, Inc.

You currently do not have access to this article.

You may need to:

Note: If your society membership provides for full-access to this article, you may need to login on your society’s web site first.

Article Tools

You currently do not have access to this article.

You may need to:

Note: If your society membership provides for full-access to this article, you may need to login on your society’s web site first.

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.